Pediatric anesthesia & critical care

Analgesic use and favourable patient-reported outcome measures after paediatric surgery: an analysis of registry data

Br J AnaesthPublished Retrospective analysis of registry data

Authors' conclusion

The results indicated substantial deficits in the concept, application, and dosing of analgesics in paediatric patients after surgery.

Study context

Population
Children after appendectomy or tonsillectomy, 11 European hospitals in PAIN OUT infant
Participants
898 children · 11 hospitals
Exposure
Hospitals with favourable vs unfavourable composite PRO results
Outcome
Composite PRO measure (pain intensity and pain-related interference)
Follow-up
24 h after surgery
Methodological detailsmulticentre, benchmarking, multinomial regression
  • Multicentre
  • Benchmarking
  • Multinomial regression

Main finding

As reported in the abstract

Full daily doses of non-opioid analgesics (NSAID, paracetamol, metamizole) · first 24 h after surgery

P < 0.001

Observational data: associations, not effects.

Further findings

Factors associated with allocation to Group III vs Group I (multinomial regression)

OR (95% CI)
Lower number of full daily doses of non-opioid analgesics0.22 (0.15–0.31)
Less dexamethasone0.49 (0.33–0.71)
Fewer non-opioid analgesics before end of surgery0.37 (0.22–0.62)
OutcomeGroup IGroup IIIP value
Intraoperative dexamethasoneGroup I vs Group III70.1%52.6%P < 0.001
  • Factors associated with allocation to Group III vs Group I (multinomial regression): Nagelkerke's R2=0.433

Factors associated with allocation to Group III vs Group I (multinomial regression)

Higher opioid doses associated with allocation to Group III vs Group I

Original publication

Analgesic use and favourable patient-reported outcome measures after paediatric surgery: an analysis of registry data. Br J Anaesth. Published 5 December 2022. doi:10.1016/j.bja.2022.09.028

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.